Integration of proteomics data helped in the identification of potential 20q candidates, including HNF4A (hepatocyte nuclear factor 4, alpha), TOMM34 (translocase of outer mitochondrial membrane 34), and SRC (SRC proto-oncogene, nonreceptor tyrosine kinase).5 In another study, integrating metabolomics and transcriptomics yielded molecular perturbations underlying prostate cancer. This evidence concerns the gene TOMM34 and prostate carcinoma.